Show simple item record

dc.contributor.authorKuria, JG
dc.contributor.authorAmayo, A.
dc.date.accessioned2013-10-23T07:13:25Z
dc.date.available2013-10-23T07:13:25Z
dc.date.issued2008-09
dc.identifier.citationEast Afr Med J. 2008 Sep;85(9):459-62.en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/19537420
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/57839
dc.description.abstractOBJECTIVE: To determine prevalence of thyroid antimicrosomal and antithyroglobulin antibodies among patients with primary thyroid disorders. DESIGN: Descriptive cross-sectional study. SETTING: Kenyatta National Hospital, July 2003 to August 2004. RESULTS: Antimicrosomal antibodies (anti-TPOAbs) were detected in 51.4% of all the patients while 36.1% tested positive for the antithyroglobulin antibodies (anti- TgAbs). Among the hyperthyroid patients, anti-TPOAbs and anti-TgAbs were in 50.8% and 33% respectively while 53.3% and 46.7% of the hypothyroid patients tested positive for anti-TPOAbs and anti-TgAbs respectively. Most of the patients who showed positivity for anti-TgAbs (88.5%) also tested positive for anti-TPOAbs. CONCLUSION: More than half of the patients with primary thyroid disorders show presence of autoimmune thyroid markers, with anti TPO antibodies being more prevalent.en
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.titlePrevalence of anti-thyroid antibodies in patients with primary thyroid disorders.en
dc.typeArticleen
local.publisherschool of public healthen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record